Incannex Healthcare, Indivior, and Tilray Brands are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cannabis industry—ranging from growers and processors of medical or recreational marijuana to ancillary businesses like equipment suppliers and biotech firms developing cannabinoid-based therapies. By buying these equities, investors gain exposure to a rapidly expanding market driven by changing regulations and consumer demand. However, cannabis stocks also carry heightened regulatory, legal and market-volatility risks compared with many other sectors. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Incannex Healthcare (IXHL)
Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read Our Latest Research Report on INDV
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Read Our Latest Research Report on TLRY
Featured Articles
- MarketBeat’s Top Five Stocks to Own in August 2025
- Zillow Group Approaching Key Technical Levels: Is It Time to Buy?
- For True Diversification: 3 Stocks You Can Buy Now
- Workday: Institutions Are Buying This Stock, Shouldn’t You?
- MarketBeat Week in Review – 08/18 – 08/22
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook